(株)メドレックスの貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|
| 東証GRT | 医薬品 | 4586/ - | - |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|
| 2015/04/10 | 日証協 | 557,700株 | +1.03% | 24,800株 | +87.88% | 410,235株 | +2.37% | 20,700株 | -3.72% |
| 2015/04/03 | 日証協 | 552,000株 | +1.47% | 13,200株 | -60.36% | 400,735株 | +4.81% | 21,500株 | +99.06% |
| 2015/03/20 | 日証協 | 540,100株 | -0.52% | 4,200株 | +600% | 381,324株 | -0.47% | 1,610株 | +46.36% |
| 2015/03/13 | 日証協 | 542,900株 | -0.84% | 600株 | -83.78% | 383,124株 | -0.67% | 1,100株 | -65.73% |
| 2015/03/06 | 日証協 | 547,500株 | -0.67% | 3,700株 | -59.78% | 385,714株 | -0.36% | 3,210株 | +28.4% |
| 2015/02/27 | 日証協 | 551,200株 | +0.82% | 9,200株 | -71.25% | 387,114株 | +0.97% | 2,500株 | -49.08% |
| 2015/02/20 | 日証協 | 546,700株 | -0.49% | 32,000株 | +263.64% | 383,414株 | -0.36% | 4,910株 | -42.91% |
| 2015/02/13 | 日証協 | 549,400株 | +3.41% | 8,800株 | -42.11% | 384,804株 | +3.83% | 8,600株 | -4.44% |
| 2015/02/06 | 日証協 | 531,300株 | -3.97% | 15,200株 | -67.66% | 370,604株 | -4.88% | 9,000株 | -20.35% |
| 2015/01/30 | 日証協 | 553,239株 | -1.91% | 47,000株 | +9999.99% | 389,604株 | -0.54% | 11,300株 | +1155.56% |
| 2015/01/23 | 日証協 | 564,039株 | -5.78% | 100株 | -90% | 391,704株 | -3.65% | 900株 | -87.67% |
| 2015/01/16 | 日証協 | 598,639株 | -3.67% | 1,000株 | -97.09% | 406,527株 | -1.88% | 7,300株 | -33.03% |
| 2015/01/09 | 日証協 | 621,439株 | -1.75% | 34,400株 | +9999.99% | 414,327株 | +3.97% | 10,900株 | -15.52% |
| 2014/12/30 | 日証協 | 632,539株 | -3.04% | 200株 | -97.5% | 398,524株 | -5.48% | 12,903株 | +180.5% |
| 2014/12/26 | 日証協 | 652,339株 | -4.26% | 8,000株 | -86.94% | 421,631株 | -1.65% | 4,600株 | +63.12% |
| 2014/12/19 | 日証協 | 681,339株 | -2.85% | 61,239株 | +31.7% | 428,721株 | -4.8% | 2,820株 | -54.52% |
| 2014/12/12 | 日証協 | 701,300株 | -0.14% | 46,500株 | +229.79% | 450,345株 | +0.18% | 6,200株 | -60.51% |
| 2014/12/05 | 日証協 | 702,300株 | -8.88% | 14,100株 | -88.57% | 449,545株 | -6.92% | 15,700株 | -34.31% |
| 2014/11/28 | 日証協 | 770,700株 | +5.75% | 123,400株 | +60.89% | 482,945株 | +4.14% | 23,901株 | +35.78% |
※株式分割は考慮していませんのでご注意ください。
Page Top